U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07233382) titled 'ASSESSING THE EFFICACY OF PROBIOTICS IN PREVENTION OF NEC IN PRETERM BABIES' on Nov. 14.
Brief Summary: The goal of the study is to check efficacy of probiotics in preventing necrotizing enterocolitis. The main questions would be if the preterm baby developed NEC or not.
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
NEC
NEC - Necrotizing Enterocolitis
Intervention:
DRUG: Probiotic
All preterm babies <34 weeks Gestational age admitted within 24 hrs of life will be eligible for the study. Those full filling inclusion criteria and consenting to participate will be recruited. Consent will be obtained by team not...